Michelle Werner

Michelle Werner serves as a Member of the Board of Directors at Omega Therapeutics and is the Chief Executive Officer of Alltrna. In addition, Michelle holds the position of CEO Partner at Flagship Pioneering and is a Member of Chief. Previously, Michelle was the Global Franchise Head for Solid Tumors at Novartis Oncology. Educational qualifications include an MBA in Marketing from London Business School (2003-2005) and participation in Executive Education at Harvard Business School (2018).